DH241220P17500
- 0.00
- 0.000.00%
Definitive Healthcare Newsroom
Surging Earnings Estimates Signal Upside for Definitive Healthcare (DH) Stock
Definitive Healthcare Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
BTIG Maintains Definitive Healthcare(DH.US) With Buy Rating, Maintains Target Price $7
Buy Recommendation on Definitive Healthcare Corp Amid Strategic Initiatives and Growth Potential
Definitive Healthcare Corp. (DH)) Q3 2024 Earnings Call Transcript Summary
Definitive Healthcare Corp. (NASDAQ:DH) Just Reported, And Analysts Assigned A US$5.28 Price Target
A Quick Look at Today's Ratings for Definitive Healthcare(DH.US), With a Forecast Between $5 to $6
Express News | Definitive Healthcare Corp : Stifel Cuts Target Price to $6 From $7.5
Needham Maintains Definitive Healthcare(DH.US) With Hold Rating
Needham Reaffirms Their Hold Rating on Definitive Healthcare Corp (DH)
Express News | Needham Reiterates Hold on Definitive Healthcare
Definitive Healthcare Analyst Ratings
Definitive Healthcare GAAP EPS of -$1.12, Revenue of $62.7M
Definitive Healthcare | 8-K: Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024
Earnings Preview: DH to Report Financial Results on November 07
Definitive Healthcare Corp. (DH) Beats Q3 Earnings and Revenue Estimates
Express News | Definitive Healthcare : On November 1 Authorized Stock Repurchase Program of up to $100.0 Mln of Class a Common Stock, That Expires on Dec 31, 2025
Express News | Definitive Healthcare Corp: CFO Richard Booth to Leave Effective June 1, 2025
Definitive Healthcare Announces CFO Departure and Stock Buyback
Definitive Healthcare | 10-Q: Q3 2024 Earnings Report